Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q1 2019 · 10-Q
Revenue$2.35B$2.35B−0.9% vs Q1 2018 Net Income-$14.10M-$14.10MN/M vs Q1 2018 EPS Diluted-$0.23-$0.23N/M vs Q1 2018 Gross Profit$276,621,000−14.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flow-$60,904,000N/M Free Cash Flowderived-$72,578,000N/M Margins · derivedGross margin11.8%−1.9 pt vs Q1 2018
Operating margin0.7%−0.3 pt vs Q1 2018
Net margin-0.6%−0.9 pt vs Q1 2018
ended Mar 31, 2019 · filed May 7, 2019 · 37 d after period end